| RS1593133607 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593133714 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593144167 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593144544 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593144887 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593145590 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1593147785 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593157923 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1593181774 |
CDX2
|
Health Risk |
Likely pathogenic |
Sirenomelia, Sirenomelia |
| RS1593197637 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1593199545 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1593199583 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1593199703 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1593199801 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1593199940 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1593201632 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1593201647 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1593201677 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1593201811 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1593201815 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Familial cancer of breast |
| RS1593201819 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593201999 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593202112 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1593202166 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Familial cancer of breast |
| RS1593202253 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1593202262 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1593216248 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1593218885 |
CDK8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with hypotonia and behavioral abnormalities, Intellectual developmental disorder with hypotonia and behavioral abnormalities |
| RS1593218890 |
CDK8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with hypotonia and behavioral abnormalities, Intellectual developmental disorder with hypotonia and behavioral abnormalities |
| RS1593223800 |
RAB23
|
Health Risk |
Pathogenic |
RAB23-related Carpenter syndrome, RAB23-related Carpenter syndrome |
| RS1593223920 |
RAB23
|
Health Risk |
Pathogenic |
Carpenter syndrome, Carpenter syndrome |
| RS1593238375 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1593258510 |
B3GLCT
|
Health Risk |
Pathogenic |
Peters plus syndrome, Peters plus syndrome |
| RS1593269476 |
CNOT2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with nasal speech, dysmorphic facies |
| RS1593275363 |
POLR1D
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 2, Treacher Collins syndrome 2 |
| RS1593275448 |
POLR1D
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 2, Treacher Collins syndrome 2 |
| RS1593275599 |
POLR1D
|
Health Risk |
Likely pathogenic |
Treacher Collins syndrome 2, Treacher Collins syndrome 2 |
| RS1593275616 |
POLR1D
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 2, Treacher Collins syndrome 2 |
| RS1593287730 |
MTRFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 7, Spastic paraplegia |
| RS1593295876 |
SLC25A15
|
Health Risk |
Pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1593310364 |
CDK8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with hypotonia and behavioral abnormalities, Intellectual developmental disorder with hypotonia and behavioral abnormalities |
| RS1593326999 |
ATP8A2
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1593332981 |
GJA3
|
Health Risk |
Pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS1593351503 |
GJB2
|
Health Risk |
Pathogenic |
Noonan syndrome 1, Noonan syndrome 1 |
| RS1593356841 |
PPFIBP1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS1593376626 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome 13, Joubert syndrome 13 |
| RS1593379577 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS1593402927 |
COG6
|
Health Risk |
Likely pathogenic |
COG6-congenital disorder of glycosylation, COG6-congenital disorder of glycosylation |
| RS1593410369 |
ATP8A2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1593411974 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593412002 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary retinoblastoma |
| RS1593412158 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1593412261 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1593412262 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593414337 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1593418044 |
COG6
|
Health Risk |
Likely pathogenic |
— |
| RS1593418085 |
COG6
|
Health Risk |
Likely pathogenic |
COG6-congenital disorder of glycosylation, COG6-congenital disorder of glycosylation |
| RS1593421620 |
COG6
|
Health Risk |
Pathogenic |
COG6-congenital disorder of glycosylation, COG6-congenital disorder of glycosylation |
| RS1593434175 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593434250 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1593438023 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1593443514 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593445096 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593445220 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593445246 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593448449 |
RB1
|
Health Risk |
Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593453973 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593454115 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593455621 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1593456963 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593457065 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1593457070 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary retinoblastoma |
| RS1593457108 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593457156 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593470515 |
RNASEH2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 2, Aicardi-Goutieres syndrome 2 |
| RS1593477057 |
SUCLA2
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS1593479845 |
SUCLA2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS1593528532 |
CPAP
|
Health Risk |
Likely pathogenic |
— |
| RS1593529868 |
RB1
|
Health Risk |
Likely pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1593531290 |
ATP8A2
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1593531889 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1593532084 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593532101 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593534586 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593534748 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593538130 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Malignant tumor of urinary bladder, Retinoblastoma |
| RS1593538155 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593538175 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593538220 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593538236 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Sarcoma |
| RS1593539163 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593539225 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593539366 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593539386 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1593539435 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593539493 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593539538 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1593544633 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1593544647 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1593576872 |
ATP8A2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |